CPRX
Price
$15.01
Change
-$0.19 (-1.25%)
Updated
May 2, 1:54 PM EST
6 days until earnings call
RNA
Price
$25.47
Change
-$0.31 (-1.20%)
Updated
May 2, 11:02 AM EST
5 days until earnings call
Ad is loading...

Analysis and predictions CPRX vs RNA

Header iconCPRX vs RNA Comparison
Open Charts CPRX vs RNABanner chart's image
Catalyst Pharmaceuticals
Price$15.01
Change-$0.19 (-1.25%)
Volume$732
CapitalizationN/A
Avidity Biosciences
Price$25.47
Change-$0.31 (-1.20%)
Volume$300
CapitalizationN/A
View a ticker or compare two or three
CPRX vs RNA Comparison Chart

Loading...

CPRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CPRX vs. RNA commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Hold and RNA is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (CPRX: $15.20 vs. RNA: $25.80)
Brand notoriety: CPRX and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 53% vs. RNA: 90%
Market capitalization -- CPRX: $1.79B vs. RNA: $2.47B
CPRX [@Biotechnology] is valued at $1.79B. RNA’s [@Biotechnology] market capitalization is $2.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, CPRX is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 2 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • CPRX’s TA Score: 2 bullish, 5 bearish.
  • RNA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RNA is a better buy in the short-term than CPRX.

Price Growth

CPRX (@Biotechnology) experienced а +0.53% price change this week, while RNA (@Biotechnology) price change was +2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.74%. For the same industry, the average monthly price growth was -2.38%, and the average quarterly price growth was +1240.99%.

Reported Earning Dates

CPRX is expected to report earnings on Aug 07, 2024.

RNA is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+4.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CPRX with price predictions.
OPEN
A.I.dvisor published
a Summary for RNA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RNA($2.47B) has a higher market cap than CPRX($1.79B). RNA YTD gains are higher at: 185.083 vs. CPRX (-9.578).
CPRXRNACPRX / RNA
Capitalization1.79B2.47B73%
EBITDAN/AN/A-
Gain YTD-9.578185.083-5%
P/E Ratio24.13N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
28
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPRXRNA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
70%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
CPRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IYSCX11.000.01
+0.09%
Delaware Ivy Smid Cap Core Fund Class C
CHASX14.22N/A
N/A
Chase Growth N
CBHCX8.32N/A
N/A
Victory Market Neutral Income C
MAPAX28.22-0.03
-0.11%
MainStay WMC Value A
RSLCX60.29-0.07
-0.12%
American Funds SMALLCAP World R3

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with MNKD. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+1.00%
MNKD - CPRX
40%
Loosely correlated
+5.60%
VCEL - CPRX
39%
Loosely correlated
+2.75%
ABOS - CPRX
38%
Loosely correlated
+0.93%
RNA - CPRX
37%
Loosely correlated
+6.92%
PCVX - CPRX
37%
Loosely correlated
+5.22%
More

RNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNA has been loosely correlated with DYN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RNA jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNA
1D Price
Change %
RNA100%
+6.92%
DYN - RNA
44%
Loosely correlated
+2.05%
RLAY - RNA
44%
Loosely correlated
+2.15%
SWTX - RNA
42%
Loosely correlated
+0.32%
SNDX - RNA
42%
Loosely correlated
+3.83%
GERN - RNA
42%
Loosely correlated
+3.69%
More